Nebulized corticosteroids and pediatricians: Results of the NUAGES survey;Prescription des corticoïdes nébulisés par les pédiatres : résultats de l'enquête NUAGES

Archives de Pediatrie

Volumn 15, Issue 10, 2008, Pages 1520-1524

  Salles, M ^a   de Monte, M ^b,c   Dubus, J C ^a,c   Diot, P ^b,c  

^a TIMONE HOSPITAL   (France)

^b UNIVERSITÉ DE TOURS   (France)

^c Groupe Aerosoltherapie (GAT) Societe de pneumologie de langue francaise   (France)

Author keywords

[No Author keywords available]

Indexed keywords

BUDESONIDE; CORTICOSTEROID;

ARTICLE; ASTHMA; DATA ANALYSIS; DEVICE; DRUG USE; FRANCE; NEBULIZATION; NEBULIZER; PEDIATRICIAN; PRESCRIPTION; RESPIRATORY TRACT DISEASE; SUSPENSION; THERAPY EFFECT; TRAINING;

ADRENAL CORTEX HORMONES; DRUG PRESCRIPTIONS; FRANCE; HUMANS; NEBULIZERS AND VAPORIZERS; PEDIATRICS; PHYSICIAN'S PRACTICE PATTERNS; QUESTIONNAIRES;

EID: 53649088443     PISSN: 0929693X     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.arcped.2008.07.015     Document Type: Article

References (19)

1. Pauwels R., Newman S., and Borgström L. Airway deposition and airway effects of antiasthma drugs delivered from metered-dose inhalers. Eur Respir J 10 (1997) 2127-2138
2. de Monte M., Dubus J.C., Chaumuzeau J.P., et al. NUAGES : une enquête sur la pratique de le nébulisation en France. Rev Mal Respir 25 (2008) 43-49
3. De Blic J., Delacourt C., Le Bourgeois M., et al. Efficacy of nebulized budesonide in severe infantile asthma: a double blind study. J Allergy Clin Immunol 98 (1996) 14-20
4. De Blic J, Scheinmann P. Stratégie thérapeutique : traitement de fond de l'asthme. In: Les médicaments de l'asthme chez l'enfant. Recherche clinique et décision thérapeutique. Paris: Springer Verlag France; 2000. p. 205-14.
5. Bisgaard H. Clinical efficacy of nebulised drugs. J Aerosol Med 7 (1994) S33-S37
6. Global initiative for asthma (GINA). Global strategy for asthma management and prevention. NIH publication No. 02-3659 2002 www.ginasthma.com.
7. Shapiro G., Mendelson L., Kraemer M.J., et al. Efficacy and safety of budesonide inhalation suspension in children with inhaled steroid-dependent persistant asthma. J Allergy Clin Immunol 102 (1998) 789-796
8. Baker J.W., Mellon M., Wald J., et al. A multiple-dosing, placebo-controlled study of budesonide inhalation suspension given once or twice daily for treatment of persistant asthma in young children and infants. Pediatrics 103 (1999) 414-421
9. Kemp J.P., Skoner D.P., Szefler S.J., et al. Once daily budesonide inhalation suspension for the treatment of persistant asthma in infants and young children. Ann Allergy Asthma Immunol 83 (1999) 231-239
10. Klassen T.P., Craig W.R., Moher D., et al. Nebulized budesonide and oral dexamethasone for treatment of croup: a randomised controlled trial. JAMA 279 (1998) 1629-1632
11. Geelhoed G.C., and Macdonald W.B. Oral and inhaled steroids in croup: a randomised placebo-controlled trial. Pediatr Pulmonol 20 (1995) 355-361
12. Fitzgerald D., Mellis C., Johnson M., et al. Nebulized budesonide is as effective as nebulized adrenaline in moderately severe croup. Pediatrics 97 (1996) 722-725
13. Dautzenberg B., Becquemin M.H., Chaumuzeau J.P., et al. Bonne pratique de l'aérosolthérapie par nébulisation. Rev Mal Respir 24 (2007) 751-757
14. Groupe Aérosolthérapie. Module de formation en aérosolthérapie. www.splf.org.
15. McKenzie J.E., and Cruz-Rivera M. Compatibility of budesonide inhalation suspension with four nebulizing solution. Ann Pharmacother 38 (2004) 967-972
16. Nikander K., Turpeinen M., and Wollmer P. The conventional ultrasonic nebulizer proved ineficient in nebulizing a suspension. J Aerosol Med 12 (1999) 47-53
17. Boe J., Dennis J.H., O'Driscoll B.R., et al. Adaptations des recommandations de l'European Respiratory Society sur l'aérosolthérapie par nébulisation par le Groupe Aérosolthérapie de la Société de pneumologie de langue française. Rev Mal Respir 21 (2004) 1033-1038
18. Nikander K. Drug delivery systems. J Aerosol Med 7 (1994) S19-S24
19. Mellon M., Leflein J., Walton-Bowen K., et al. Comparable efficacy of administration with face mask or mouthpiece of nebulized budesonide inhalation suspension for infants and young children with persistant asthma. Am J Respir Crit Care Med 162 (2000) 593-598